The Business Times

Johnson & Johnson

International

J&J faces first UK lawsuits alleging its baby powder caused cancer

J&J would also announce plans for additional manufacturing facilities in the US and the expansion of current US sites in the coming months.
Consumer & Healthcare

Johnson & Johnson to invest US$2 billion to boost US manufacturing as drug tariffs loom

J&J has been attempting to resolve the lawsuits through a subsidiary company’s bankruptcy, after two previous bankruptcy attempts failed in other courts.
Companies & Markets

US judge rejects J&J’s US$10 billion baby powder settlement

IRVINE, CALIFORNIA - OCTOBER 17: The Johnson & Johnson logo is displayed at company offices on October 17, 2023 in Irvine, California. Johnson & Johnson beat Wall Street’s quarterly revenue and earnings estimates as sales in its pharmaceutical and medical devices businesses grew. Mario Tama/Getty Images/AFP (Photo by MARIO TAMA / GETTY IMAGES NORTH AMERICA / Getty Images via AFP)
Consumer & Healthcare

Johnson & Johnson is in talks to buy US$10 billion biotech Intra-Cellular

J&J faces lawsuits from more than 62,000 plaintiffs alleging its baby powder and other talc products were contaminated with asbestos.
Consumer & Healthcare

J&J talc bankruptcy stays in Texas despite ‘forum-shopping’ opposition

The increase would boost the size of the settlement to more than US$9 billion paid over 25 years.
Consumer & Healthcare

Johnson & Johnson adds US$1.1 billion to proposed talc settlement

FILE PHOTO: Johnson & Johnson company offices are shown in Irvine, California, U.S., October 14, 2020. REUTERS/Mike Blake
Companies & Markets

J&J to pay as much as US$1.7 billion for heart-tech firm V-Wave

The settlement offer includes claims that the talc-based version caused ovarian and other gynaecological cancers.
Consumer & Healthcare

J&J gets plaintiff backing for US$6.5 billion baby powder accord

In its settlement with 42 states and the District of Columbia, Johnson & Johnson did not admit wrongdoing, even though it withdrew its talcum-based powder from the North American market in 2020.
Companies & Markets

Johnson & Johnson reaches US$700 million talc case settlement

The deal has potential for an additional milestone payment, J&J said.
Consumer & Healthcare

J&J to acquire Proteologix for US$850 million

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More